Skip to main content
Premium Trial:

Request an Annual Quote

Seattle Biomedical Research Institute Lands $30.6M to Establish Structural Genomics Center

NEW YORK (GenomeWeb News) – The Seattle Biomedical Research Institute will use a $30.6 million contract award from the National Institute for Allergy and Infectious Diseases to run a collaborative initiative aimed at using genomics and translational research methods to study a number of diseases, the institute said recently.
 
SBRI will use the five-year contract to start the Seattle Structural Genomics Center for Infectious Disease, and it will work with researchers at the University of Washington, Battelle Northwest, and Decode Biostructures, which is a subsidiary of Decode Genetics.
 
The goal of the center is to determine the three-dimensional structures of proteins from bacterial, viral, fungal, and protozoan pathogens that cause emerging and re-emerging infectious diseases, SBRI said, in order to develop a “blueprint” to be used in development of new drug treatments.
 
“By determining the three-dimensional structure of these proteins, we can identify important pockets or clefts and design small molecules which will disrupt their disease-causing function,” SBRI Principal Investigator Peter Myler said in a statement.
 
Myler aims for the center to solve 75 to 100 protein structures per year, with the results of the research being published and shared with scientists around the world.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.